Global Asthma and COPD Drugs Market Size Study & Forecast, by Diseases, by Medication Class, and Regional Analysis, 2023-2030

Description

List of Tables

Global Asthma and COPD Drugs Market is valued at approximately USD 36.12 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 4.64% over the forecast period 2023-2030. Asthma and COPD drugs are medications used to manage and treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Both asthma and COPD are chronic respiratory diseases characterized by inflammation and narrowing of the airways, leading to symptoms such as wheezing, shortness of breath, coughing, and chest tightness. The Asthma and COPD Drugs Market is expanding because of factors such as the growing trend of personalized therapy, changing lifestyle patterns, and increasing government support, coupled with better access to healthcare services.

In addition, the increasing prevalence of asthma and COPD is acting as a catalyzing factor for market growth across the globe. Asthma and COPD are chronic respiratory diseases with a significant global burden. According to the World Health Organization (WHO), respiratory disease infection is considered the third major cause of death with approximately 3 million death per year (6% of global deaths), in which nearly 90% of COPD fatalities occur in those 70-year-old people from the low-and middle-income countries. Also, there are around 262 million patients estimated to suffer from asthma, which commonly affects children. Thus, the increasing prevalence of these conditions, driven by factors such as air pollution, smoking, aging populations, and changing lifestyles, contributes to the growing demand for effective medications to manage and treat asthma and COPD, which, in turn, propelling the growth of the Asthma and COPD Drugs Market during the estimated period. Moreover, the technological advancements in drug development, as well as the increasing awareness about asthma and COPD, along with improved diagnostic techniques present various lucrative opportunities over the forecast years. However, the side effects associated with drugs and stringent government regulations for product approvals are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Asthma and COPD Drugs Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing research and development activities, along with the rise in the number of fundings undertaken by government and non-government organizations. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The rising healthcare expenditure, favorable reimbursement policies, increasing aging population, as well as favorable reimbursement policies are significantly propelling the market demand across the region.

Major market players included in this report are:

Vectura Group Limited
Abbott Laboratories
Glaxosmithkline Plc
Sanofi
Organon
F. Hoffmann-La Roche AG
Novartis AG
Boehringer Ingelheim International GmbH
Teva Pharmaceutical Industries Ltd
AstraZeneca Plc

Recent Developments in the Market:

In October 2022, Verona reported positive analyses of Ensifentrine, a medication used to treat chronic obstructive pulmonary disease (COPD), which was the subject of a phase 3 clinical trial. Ensifentrine combines bronchodilator and anti-inflammatory properties into a single substance.
In June 2022, Glenmark introduced the innovative fixed dose combination (FDC) medication Indacaterol with Mometasone for patients in India with unmanageable asthma. This FDC was introduced by the business under the Indamet brand.

Global Asthma and COPD Drugs Market Report Scope:

Historical Data: 2020 - 2021
Base Year for Estimation: 2022
Forecast period: 2023-2030
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Diseases, Medication Class, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Diseases:

Asthma
COPD

By Medication Class:

Combination Drugs
Short Acting Beta Agonists (SABA)
Long Acting Beta Agonists (LABA)
Leukotriene Antagonists (LTA)
Anticholinergics
Others

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Asthma and COPD Drugs Market, by Region, 2020-2030 (USD Billion)
- 1.2.2. Asthma and COPD Drugs Market, by Diseases, 2020-2030 (USD Billion)
- 1.2.3. Asthma and COPD Drugs Market, by Medication Class, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Asthma and COPD Drugs Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Asthma and COPD Drugs Market Dynamics

3.1. Asthma and COPD Drugs Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
  - 3.1.1.1. Increasing prevalence of asthma and COPD
  - 3.1.1.2. Rising trend of personalized therapy
- 3.1.2. Market Challenges
  - 3.1.2.1. Side effects associated with drugs
  - 3.1.2.2. Stringent government regulations for product approvals
- 3.1.3. Market Opportunities
  - 3.1.3.1. Technological advancements in drug development
  - 3.1.3.2. Increasing awareness about asthma and COPD, along with improved diagnostic techniques

Chapter 4. Global Asthma and COPD Drugs Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Asthma and COPD Drugs Market, by Diseases

5.1. Market Snapshot
5.2. Global Asthma and COPD Drugs Market by Diseases, Performance - Potential Analysis
5.3. Global Asthma and COPD Drugs Market Estimates & Forecasts by Diseases 2020-2030 (USD Billion)
5.4. Asthma and COPD Drugs Market, Sub Segment Analysis
- 5.4.1. Asthma
- 5.4.2. COPD

Chapter 6. Global Asthma and COPD Drugs Market, by Medication Class

6.1. Market Snapshot
6.2. Global Asthma and COPD Drugs Market by Medication Class, Performance - Potential Analysis
6.3. Global Asthma and COPD Drugs Market Estimates & Forecasts by Medication Class 2020-2030 (USD Billion)
6.4. Asthma and COPD Drugs Market, Sub Segment Analysis
- 6.4.1. Combination Drugs
- 6.4.2. Short Acting Beta Agonists (SABA)
- 6.4.3. Long Acting Beta Agonists (LABA)
- 6.4.4. Leukotriene Antagonists (LTA)
- 6.4.5. Anticholinergics
- 6.4.6. Others

Chapter 7. Global Asthma and COPD Drugs Market, Regional Analysis

7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Asthma and COPD Drugs Market, Regional Market Snapshot
7.4. North America Asthma and COPD Drugs Market
- 7.4.1. U.S. Asthma and COPD Drugs Market
  - 7.4.1.1. Diseases breakdown estimates & forecasts, 2020-2030
  - 7.4.1.2. Medication Class breakdown estimates & forecasts, 2020-2030
- 7.4.2. Canada Asthma and COPD Drugs Market
7.5. Europe Asthma and COPD Drugs Market Snapshot
- 7.5.1. U.K. Asthma and COPD Drugs Market
- 7.5.2. Germany Asthma and COPD Drugs Market
- 7.5.3. France Asthma and COPD Drugs Market
- 7.5.4. Spain Asthma and COPD Drugs Market
- 7.5.5. Italy Asthma and COPD Drugs Market
- 7.5.6. Rest of Europe Asthma and COPD Drugs Market
7.6. Asia-Pacific Asthma and COPD Drugs Market Snapshot
- 7.6.1. China Asthma and COPD Drugs Market
- 7.6.2. India Asthma and COPD Drugs Market
- 7.6.3. Japan Asthma and COPD Drugs Market
- 7.6.4. Australia Asthma and COPD Drugs Market
- 7.6.5. South Korea Asthma and COPD Drugs Market
- 7.6.6. Rest of Asia Pacific Asthma and COPD Drugs Market
7.7. Latin America Asthma and COPD Drugs Market Snapshot
- 7.7.1. Brazil Asthma and COPD Drugs Market
- 7.7.2. Mexico Asthma and COPD Drugs Market
7.8. Middle East & Africa Asthma and COPD Drugs Market
- 7.8.1. Saudi Arabia Asthma and COPD Drugs Market
- 7.8.2. South Africa Asthma and COPD Drugs Market
- 7.8.3. Rest of Middle East & Africa Asthma and COPD Drugs Market

Chapter 8. Competitive Intelligence

8.1. Key Company SWOT Analysis
- 8.1.1. Company 1
- 8.1.2. Company 2
- 8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
- 8.3.1. Vectura Group Limited
  - 8.3.1.1. Key Information
  - 8.3.1.2. Overview
  - 8.3.1.3. Financial (Subject to Data Availability)
  - 8.3.1.4. Product Summaryd
  - 8.3.1.5. Recent Developments
- 8.3.2. Abbott Laboratories
- 8.3.3. Glaxosmithkline Plc
- 8.3.4. Sanofi
- 8.3.5. Organon
- 8.3.6. F. Hoffmann-La Roche AG
- 8.3.7. Novartis AG
- 8.3.8. Boehringer Ingelheim International GmbH
- 8.3.9. Teva Pharmaceutical Industries Ltd
- 8.3.10. AstraZeneca Plc

Chapter 9. Research Process

9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Asthma and COPD Drugs Market, report scope
TABLE 2. Global Asthma and COPD Drugs Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Asthma and COPD Drugs Market estimates & forecasts by Diseases 2020-2030 (USD Billion)
TABLE 4. Global Asthma and COPD Drugs Market estimates & forecasts by Medication Class 2020-2030 (USD Billion)
TABLE 5. Global Asthma and COPD Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 6. Global Asthma and COPD Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Asthma and COPD Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Asthma and COPD Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Asthma and COPD Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Asthma and COPD Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Asthma and COPD Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Asthma and COPD Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Asthma and COPD Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Asthma and COPD Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. U.S. Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 17. U.S. Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. Canada Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 19. Canada Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 20. Canada Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. UK Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 22. UK Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 23. UK Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. Germany Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 25. Germany Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 26. Germany Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. France Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 28. France Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 29. France Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. Italy Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 31. Italy Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 32. Italy Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Spain Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 34. Spain Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 35. Spain Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. RoE Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 37. RoE Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 38. RoE Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. China Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 40. China Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 41. China Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. India Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 43. India Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 44. India Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. Japan Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 46. Japan Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 47. Japan Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. South Korea Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 49. South Korea Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 50. South Korea Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. Australia Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 52. Australia Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 53. Australia Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. RoAPAC Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 55. RoAPAC Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 56. RoAPAC Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. Brazil Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 58. Brazil Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 59. Brazil Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Mexico Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 61. Mexico Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 62. Mexico Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. RoLA Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 64. RoLA Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 65. RoLA Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. Saudi Arabia Asthma and COPD Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 67. South Africa Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 68. RoMEA Asthma and COPD Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Asthma and COPD Drugs Market
TABLE 70. List of primary sources, used in the study of global Asthma and COPD Drugs Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

FIG 1. Global Asthma and COPD Drugs Market, research methodology
FIG 2. Global Asthma and COPD Drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Asthma and COPD Drugs Market, key trends 2022
FIG 5. Global Asthma and COPD Drugs Market, growth prospects 2023-2030
FIG 6. Global Asthma and COPD Drugs Market, porters 5 force model
FIG 7. Global Asthma and COPD Drugs Market, pest analysis
FIG 8. Global Asthma and COPD Drugs Market, value chain analysis
FIG 9. Global Asthma and COPD Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Asthma and COPD Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Asthma and COPD Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Asthma and COPD Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Asthma and COPD Drugs Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Asthma and COPD Drugs Market, regional snapshot 2020 & 2030
FIG 15. North America Asthma and COPD Drugs Market 2020 & 2030 (USD Billion)
FIG 16. Europe Asthma and COPD Drugs Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Asthma and COPD Drugs Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Asthma and COPD Drugs Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Asthma and COPD Drugs Market 2020 & 2030 (USD Billion)